|Articles|October 18, 2012

Low-dose SSRI formulation shows promise for vasomotor symptoms

A new formulation of a selective serotonin receptor inhibitor (SSRI)-low-dose mesylate of paroxetine (LDMP)-shows promise for reducing vasomotor symptoms of menopause, according to results of two studies presented at the North American Menopause Society (NAMS) conference.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Related Content

Kevin Ault, MD, on vaccines & autism, local government, HPV vaccine advocacy

ByKevin Ault, MD

February 6th 2026

Study data highlight trade-offs of testing for pregnancy too soon

ByAlexandra C. Sundermann, MD, PhD

February 6th 2026

Barbara Levy, MD, on importance of public comments on new cervical cancer screening guidance

ByBarbara Levy, MD

February 5th 2026

Minipad-based HPV testing shows promise for cervical cancer screening

ByJoshua Fitch, Senior Editor

February 5th 2026

Kevin Ault, MD, on maternal immunization, following the correct recommendations

ByKevin Ault, MD

February 4th 2026

Latest CME

Multimedia

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Multimedia

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Low-dose SSRI formulation shows promise for vasomotor symptoms

Newsletter

Related Content

Kevin Ault, MD, on vaccines & autism, local government, HPV vaccine advocacy

Study data highlight trade-offs of testing for pregnancy too soon

Barbara Levy, MD, on importance of public comments on new cervical cancer screening guidance

Minipad-based HPV testing shows promise for cervical cancer screening

Kevin Ault, MD, on maternal immunization, following the correct recommendations

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

Minipad-based HPV testing shows promise for cervical cancer screening

Study data highlight trade-offs of testing for pregnancy too soon

Barbara Levy, MD, on importance of public comments on new cervical cancer screening guidance

Kevin Ault, MD, on vaccines & autism, local government, HPV vaccine advocacy

Fionnuala McAuliffe, MD, highlights importance of timely breastfeeding discussions with patients